Friess Associates’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-97,932	Closed	-$1.8M	–	100
2020 Q3	$1.8M	Sell	97,932 -5,268	-5%	-$96.6K	0.16%	84
2020 Q2	$1.84M	Sell	103,200 -187,380	-64%	-$3.35M	0.17%	82
2020 Q1	$4.71M	Buy	+290,580	New	+$4.71M	0.47%	62